Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a sulfonyl group (-SO2-) or a nitro group (-NO2), then it may have potential side effects related to reproduction and breast disorders. The first two molecules in the dataset contain these groups and they both have labels of 1 indicating their association with such side effects.
Rule 2: If the molecule contains a conjugated system consisting of alternating double bonds and single bonds, then it may also have potential side effects related to reproduction and breast disorders. This rule applies to the third molecule in the dataset which has a label of 1.
Rule 3: If the molecule contains a halogen atom like fluorine, chlorine, bromine or iodine, then it may not have any significant side effects related to reproduction and breast disorders. None of the last four molecules in the dataset contain halogens and all have labels of 0 indicating no association with such side effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a nitro group (-NO2), then it may have potential side effects related to reproductive system and breast disorders. The first two molecules in the dataset contain these groups and they both have labels of 1, indicating their potential for causing such side effects.
Rule 2: If the molecule contains a conjugated system consisting of alternating single and double bonds, as well as an amide group (-CONH-), then it may also have potential side effects related to reproductive system and breast disorders. This structure is present in the third molecule in the dataset, which has a label of 1.
Rule 3: If the molecule contains a benzene ring connected to a nitrogen atom through a single bond, followed by another carbon atom bonded to a hydroxyl group (-OH), then it may also have potential side effects related to reproductive system and breast disorders. This structure is present in the sixth molecule in the dataset, which has a label of 1.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a functional group such as "CC(C)NO" or "CCON" in its structure, then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules #6, #7, #8, #9, #10, #11, #12, #13, #14, #15, #16, #17, #18, #19, #20, #21, #22, #23, #24, #25, #26, #27, #28, #29, #30, #31, #32, #33, #34, #35, #36, #37, #38, #39, #40, #41, #42, #43, #44, #45, #46, #47, #48, #49, #50, #51, #52, #53, #54, #55, #5

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains the substructure "C1=CC=C2C(=C1)C=NN=C2NN" or "C(CC(C(F)F)(C(=O)O)N)CN", then it may have side effects related to reproduction and breast disorders.
Rule 2: If the molecule contains the substructure "C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2", then it may have side effects related to reproduction and breast disorders.
Rule 3: If the molecule contains the substructure "CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C CCC(C1=CC=CC=C1)C(=O)O C1CN(P(=O)(OC1)NCCCl)CCCl CCS1(=O)=O", then it may have side effects related to reproduction and breast disorders.
Note that these rules are based solely on the provided dataset and may not generalize well to other molecules.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a cyano group (-CN), then it may have side effects related to reproduction and breast disorders. The first molecule in the dataset satisfies this rule as it contains a cyano group (-CN) and has been labeled as having potential side effects.
Rule 2: If the molecule contains a nitro group (-NO2), then it may have side effects related to reproduction and breast disorders. However, there is only one molecule in the dataset that contains a nitro group (-NO2) but has not been labeled as having potential side effects. Therefore, this rule cannot be confirmed based on the current dataset.
Rule 3: If the molecule contains a sulfonamide group (-SO2NH2), then it may have side effects related to reproduction and breast disorders. There are two molecules in the dataset that contain a sulfonamide group (-SO2NH2) and have been labeled as having potential side effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains a cyano group (-CN) and a benzene ring (-C6H5), then it may have potential side effects related to reproductive system and breast disorders. The first example in the dataset satisfies this rule as it contains both -CN and -C6H5 groups.
Rule 2: If the molecule contains a chlorine atom (-Cl) attached to a carbon atom adjacent to a carbonyl group (-C=O), then it may have potential side effects related to reproductive system and breast disorders. The second example in the dataset satisfies this rule as it contains -Cl and -C=O groups connected by a single bond.
Rule 3: If the molecule contains a guanidine group (-NH-C(=NH)-NH-) or a urea group (-NH-C(=O)-NH-), then it may have potential side effects related to reproductive system and breast disorders. The third example in the dataset satisfies this rule as it contains a guanidine group.

================================

Rule 1: If a compound contains a sulfonyl group (-SO2-) or a carbonyl group (-C=O) in its structure, it may have potential side effects on the reproductive system and breast disorders. The first two molecules listed in the table contain these functional groups and they both have labels indicating their association with such side effects.
Rule 2: Compounds containing aromatic rings like benzene or naphthalene may also be associated with reproductive system and breast disorders if they possess certain chemical functionalities. For example, the third molecule in the table has a benzofuran ring which is known for its estrogenic activity. It should be noted that this rule is not definitive as there could be other factors involved in causing such side effects.
Rule 3: Molecules with a nitro group (-NO2) or a cyano group (-CN) in their structures tend to have high reactivity and may pose safety concerns. The last three molecules in the table all contain one or both of these functional groups and they all have labels indicating their potential toxicity. However, it's important to note that these rules are general guidelines and should not be used as the sole basis for predicting the safety of a particular compound. Further testing and analysis would be necessary before making any conclusions about its safety.

================================

Rule 1: If there is a presence of metal ions such as calcium or copper in the molecular structure, then it may lead to adverse effects on the human body.
Rule 2: If the molecular structure contains functional groups like carbonyl group (C=O), sulfonyl group (SO2R), or nitro group (NO2), they may contribute to the toxicity of the compound.
Rule 3: If the molecular structure has a high degree of conjugation between multiple double bonds, it may increase its reactivity and potential for causing adverse effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH2) or a benzene ring with a sulfonamide substituent (-SO2NH-), then it may have side effects related to reproduction and breast disorders. The first example in the dataset contains both these features and has been labeled as having such side effects.
Rule 2: If the molecule contains a nitro group (-NO2) attached to a carbon atom adjacent to a carbonyl group (-C=O), then it may also have side effects related to reproduction and breast disorders. The second example in the dataset contains this feature but has been labeled as not having such side effects.
Rule 3: If the molecule contains a halogen atom (such as chlorine or fluorine) bonded to a carbon atom next to a double bond (-C=C-), then it may also have side effects related to reproduction and breast disorders. The third example in the dataset contains this feature but has been labeled as not having such side effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains a sodium ion (Na+) or a manganese ion (Mn+2) in its structure, then it may have potential side effects related to reproductive system and breast disorders. The presence of these ions indicates that the molecule may interact with biological systems in ways that could lead to negative health outcomes.
Rule 2: If the molecule contains a phosphate group (PO4−3), then it may also have potential side effects related to reproductive system and breast disorders. Phosphate groups are commonly found in DNA and RNA molecules, which play important roles in cell division and reproduction. Therefore, any disruption to these molecules could potentially have negative impacts on reproductive health.
Rule 3: If the molecule contains a benzene ring (C6H6) or a naphthalene ring (C10H8), then it may also have potential side effects related to reproductive system and breast disorders. These rings are common structural features in many hormones and other chemicals that regulate reproductive function. Any interference with these chemical signals could potentially disrupt normal hormonal balance and lead to negative health outcomes.

================================



================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains the substructure "CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C" or "CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C" then it may have potential side effects related to reproductive system and breast disorders. These substructures contain the thiadiazole ring which is known for its biological activities including anti-inflammatory, antibacterial, antifungal, antiviral, and anticancer properties. However, further research is needed to confirm their association with reproductive system and breast disorders.
Rule 2: If the molecule contains the substructure "CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O" then it may have potential side effects related to reproductive system and breast disorders. This substructure contains the cyclopentenone ring which is known for its biological activities including antimicrobial, antioxidant, and antitumor properties. However

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a functional group such as CC(=O) or C#N, then it may have side effects related to reproduction and breast disorders. This rule applies to molecules 1, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 in the dataset.
Rule 2: If the molecule contains chlorine atoms, then it may not have side effects related to reproduction and breast disorders. This rule applies to molecules 3, 4, 5, 6, 24 in the dataset.
Rule 3: If the molecule contains a sulfonamide group, then it may have side effects related to reproduction and breast disorders. This rule applies to molecule 2 in the dataset.
Note that these rules are based on observations from the provided dataset and may not apply to all cases. It's important to consult medical professionals before making any decisions about medication use.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains the substructure "CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C" or "CC(C)NNC(=O)c1ccc(cc1)Oc2ccccc2" then it may have potential side effects related to reproduction and breast disorders.
Rule 2: If the molecule contains the substructure "CC(C)ONC(=O)C#Cc1ccc(nc1)Nc2nnn(C)c2" then it may have potential side effects related to reproduction and breast disorders.
Rule 3: If the molecule contains the substructure "CC(C)NS(=O)(=O)C1=C(C(=C(C=C1)F)I)FC(=O)O" then it may have potential side effects related to reproduction and breast disorders.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a conjugated π-system, such as in the case of aromatic rings or double bonds, it may have a higher likelihood of causing adverse effects due to its ability to interact with biological systems. Therefore, molecules containing these structures should be labeled as having potential side effects.
Rule 2: Molecules with functional groups like carbonyls, alcohols, and amines may also contribute to their toxicity by interacting with biological macromolecules like proteins and DNA. Therefore, molecules containing these functional groups should also be considered for labeling as potentially harmful.
Rule 3: The presence of certain atoms or fragments in a molecule may indicate a higher risk of adverse effects. For example, compounds containing sulfur or chlorine may have a greater chance of causing harm to the reproductive system and breast tissue. Therefore, molecules containing these elements should be flagged as potentially dangerous.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains the substructure "CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C" or "CC(C)NNC(=O)c1ccc(cc1)Oc2ccccc2" then it may have potential side effects related to reproduction and breast disorders.
Rule 2: If the molecule contains the substructure "CC(C)ONC(=O)C#Cc1ccc(nc1)Nc2nnn(C)c2" then it may have potential side effects related to reproduction and breast disorders.
Rule 3: If the molecule contains the substructure "CC(C)NS(=O)(=O)C1=C(C(=C(C=C1)F)I)FC(=O)O" then it may have potential side effects related to reproduction and breast disorders.

================================

Rule 1: The presence of functional groups such as nitro group (-NO2) or sulfonyl group (-SO2R) in a compound may increase its potential for causing adverse effects on the reproductive system and breast tissue. This rule can be applied to the first two molecules listed above which contain these functional groups but have been labeled as having no adverse effects.
Rule 2: A compound containing a heterocyclic ring structure such as pyridine or pyrimidine may also increase the risk of adverse effects on the reproductive system and breast tissue. This rule can be applied to the third molecule listed above which contains a pyridine ring but has been labeled as having no adverse effects.
Rule 3: A compound containing halogen atoms such as chlorine or fluorine may increase the likelihood of causing adverse effects on the endocrine system due to their ability to disrupt hormonal signaling pathways. This rule can be applied to the last three molecules listed above which contain either chlorine or fluorine atoms but have been labeled as having varying degrees of adverse effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a functional group such as "CC(C)NO" or "CCON" in its structure, then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules #6, #7, #8, #9, #10, #11, #12, #13, #14, #15, #16, #17, #18, #19, #20, #21, #22, #23, #24, #25, #26, #27, #28, #29, #30, #31, #32, #33, #34, #35, #36, #37, #38, #39, #40, #41, #42, #43, #44, #45, #46, #47, #48, #49, #50, #51, #52, #53, #54, #55, #5

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains the substructure "C1=CC=C2C(=C1)C=NN=C2NN" or "C(CC(C(F)F)(C(=O)O)N)CN", then it may have side effects related to reproduction and breast disorders.
Rule 2: If the molecule contains the substructure "C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2", then it may have side effects related to reproduction and breast disorders.
Rule 3: If the molecule contains the substructure "CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C CCC(C1=CC=CC=C1)C(=O)O C1CN(P(=O)(OC1)NCCCl)CCCl CCS1(=O)=O", then it may have side effects related to reproduction and breast disorders.
Note that these rules are based solely on the provided dataset and may not generalize well to other molecules.

================================

Rule 1: If there is a presence of fluorine atom in the structure, then it may lead to adverse effects on reproduction and breast tissue. The first compound has a fluorine atom present in its structure which makes it potentially harmful for these systems.
Rule 2: A molecule containing a nitro group (-NO2) or other reactive functional groups like -SCN, -SO2NH2 etc. may have potential toxic effects due to their ability to bind with proteins and enzymes. However, this rule cannot be generalized as some molecules having such groups do not show any toxicity. The second compound contains a nitro group which may make it toxic if ingested or inhaled.
Rule 3: Molecules containing metal ions like zinc, gadolinium etc. may also exhibit certain biological activities but they should not be considered as potential drugs unless proven otherwise. The sixth compound contains a zinc ion which does not have any therapeutic use.

================================

Rule 1: If a compound contains a sulfonyl group (SO2R), it may have side effects on the reproductive system and breast disorders. The given SMILES string CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl has this functional group and hence has the potential for such side effects.
Rule 2: Compounds containing a cyano group (-CN) or a nitro group (-NO2) may also have side effects on the reproductive system and breast disorders. The given SMILES strings CCONC(C)C(=O)C1=CC=CC=C1 and C1CNN(C1)NC2=C(C=CC=C2Cl)Cl both contain these groups and thus have the potential for causing such adverse effects.
Rule 3: A compound having a thiocarbonyl group (-CS-) in its structure may be associated with adverse effects on the reproductive system and breast disorders. The given SMILES string CCC1=NC=CC(=C1)C(=S)N has this functional group and therefore has the potential for causing such side effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a benzene ring with a sulfonamide substituent (-SO2NH2), then it may have potential side effects related to reproductive system and breast disorders. The first example in the dataset contains both these features and has been labeled as having such side effects.
Rule 2: If the molecule contains a guanidine group (-CN3) or a pyridine ring with a guanidine substituent (-CH2NHCONH2), then it may also have potential side effects related to reproductive system and breast disorders. The second example in the dataset contains both these features and has been labeled as having such side effects.
Rule 3: If the molecule contains a metal ion like gallium (Ga+3) or gold (Au+), then it may have potential side effects related to reproductive system and breast disorders. However, this rule should be taken with caution since there may be other factors involved besides the presence of metals. The third example in the dataset contains Ga+3 but has been labeled as not having such side effects.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a functional group such as CC(=O) or C#N, then it may have side effects related to reproduction and breast disorders. This rule applies to molecules 1, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 in the dataset.
Rule 2: If the molecule contains chlorine atoms, then it may not have side effects related to reproduction and breast disorders. This rule applies to molecules 3, 4, 5, 6, 24 in the dataset.
Rule 3: If the molecule contains a sulfonamide group, then it may have side effects related to reproduction and breast disorders. This rule applies to molecule 2 in the dataset.
Note that these rules are based on observations from the provided dataset and may not apply to all cases. It's important to consult medical professionals before making any decisions about medication use.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproductive system and breast disorders:
Rule 1: If the molecule contains a cyano group (-CN) and a benzene ring (-C6H5), then it may have potential side effects related to reproductive system and breast disorders. The first example in the dataset satisfies this rule as it contains both -CN and -C6H5 groups.
Rule 2: If the molecule contains a chlorine atom (-Cl) attached to a carbon atom adjacent to a carbonyl group (-C=O), then it may have potential side effects related to reproductive system and breast disorders. The second example in the dataset satisfies this rule as it contains -Cl and -C=O groups connected by a single bond.
Rule 3: If the molecule contains a guanidine group (-NH-C(=NH)-NH-) or a urea group (-NH-C(=O)-NH-), then it may have potential side effects related to reproductive system and breast disorders. The third example in the dataset satisfies this rule as it contains a guanidine group.

================================

Rule 1: If there is a presence of fluorine atom in the structure, then it may lead to adverse effects on reproduction and breast tissue. The first compound has a fluorine atom present in its structure which makes it potentially harmful for these systems.
Rule 2: A molecule containing a nitro group (-NO2) or other reactive functional groups like -SCN, -SO2NH2 etc. may have potential toxic effects due to their ability to bind with proteins and enzymes. However, this rule cannot be generalized as some molecules having such groups do not show any toxicity. The second compound contains a nitro group which may make it toxic if ingested or inhaled.
Rule 3: Molecules containing metal ions like zinc, gadolinium etc. may also exhibit certain biological activities but they should not be considered as potential drugs unless proven otherwise. The sixth compound contains a zinc ion which does not have any therapeutic use.

================================

Rule 1: The presence of certain functional groups in a molecule may indicate its potential for causing adverse effects on the reproductive system or breast tissue. For example, the presence of chlorine atoms in the first SMILES string suggests that this molecule could have endocrine disrupting properties. Similarly, the presence of nitro groups in the fifth SMILES string indicates that this molecule could be toxic to the reproductive system.
Rule 2: The structure of a molecule can also play a role in determining its ability to cause adverse effects. For instance, the second SMILES string contains a sulfonamide group which is known to be toxic to the reproductive system. Additionally, the third SMILES string contains a nitrile group which is highly reactive and could potentially interact with other molecules in the body.
Rule 3: The length and complexity of a molecule can also affect its toxicity. Longer and more complex molecules tend to have higher chances of interacting with other molecules in the body and causing adverse effects. This is evident from the sixth SMILES string which has a long carbon chain and several rings.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a functional group such as "CC(C)NO" or "CCON" in its structure, then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules #6, #7, #8, #9, #10, #11, #12, #13, #14, #15, #16, #17, #18, #19, #20, #21, #22, #23, #24, #25, #26, #27, #28, #29, #30, #31, #32, #33, #34, #35, #36, #37, #38, #39, #40, #41, #42, #43, #44, #45, #46, #47, #48, #49, #50, #51, #52, #53, #54, #55, #5

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a nitro group (-NO2), then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules #7, #8, #9, #10, #11, #12, #13, #14, #15, #16, #17, #18, #19, #20, #21 in the dataset.
Rule 2: If the molecule contains a halogen atom such as chlorine (Cl) or fluorine (F), then it may not have potential side effects related to reproduction and breast disorders. This rule applies to molecules #3, #4, #5, #6, #12, #13, #14, #15, #16, #17, #18, #19, #20, #21 in the dataset.
Rule 3: If the molecule contains a cyano group (-CN) or an amide group (-CONH-), then it may have potential side effects related to reproduction and breast disorders.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If a molecule contains the substructure "CCON" or "CCNS", then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules in rows 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has potential side effects related to reproduction and breast disorders:
Rule 1: If the molecule contains a benzene ring (represented by the SMILES string "c1ccccc1" or "c1cc2ccc(cc2c1)"), then it may have potential side effects related to reproduction and breast disorders. This rule applies to molecules in rows 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62,

================================

